ArticleData in brief2024
Structured over-the-counter medicine dataset to improve the safety of pharmaceuticals.
Article in Data in brief, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Indonesian pharmaceutical dataset for self-medication.Data in brief · 2026Article
- Structured over-the-counter medicine dataset to improve the safety of pharmaceuticals.Data in brief · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Pharma-safe Index Dataset comprises comprehensive information on several aspects of pharmaceuticals, including general medication data, usage guidelines, dosage, adverse effects, pricing, drug interactions, duration of use, composition, and contraindications. The dataset is provided in both CSV and JSON file formats, and it is available in both English and Bahasa Indonesia. By conducting interviews, distributing flyers, and using pharmacy books, the dataset was collected from over-the-counter medications that were sold at three pharmacies located in Yogyakarta, Indonesia. A medical professional performed cleansing, standardization, and validation on it before it was exported to JSON and CSV formats. The data collected on drug efficacy, safety, and patient outcomes in Indonesia can be utilized by researchers in order to uncover trends and developing patterns of prescription drug resistance. It is possible that this will direct future research, lead to improvements in drug formulations, treatment strategies, and public health policies, and expand our understanding of how drugs work and how they affect patient health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.